Genomic Patent Exclusivity Tackled By NIH “Best Practices” Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
NIH is floating a three-page draft guidance on best practices for the licensing of genomic inventionsYou may also be interested in...
NIH Genomics Licensing Policy Guidance Debated By Advocacy Groups
NIH Genomics Licensing Policy Guidance Debated By Advocacy Groups
Pharmacogenomic Progress Hinges On Strong Pharma Backing – Consultant
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: